Literature DB >> 19763650

Dimethyl sulphoxide dose-response on rat retinal function.

Tina I Tsai1, Bang V Bui, Algis J Vingrys.   

Abstract

The aim of the study is to determine whether dimethyl sulphoxide (DMSO), a common laboratory solvent, impacts retinal function. Long Evans rats (n = 17) were intravitreally injected with five different doses of DMSO representative of those reported in the literature and spanning over 3 log units of vitreal concentration (0.01-8%). Retinal function was evaluated 1 h after injection using electroretinograms, and the waveform was decomposed into outer (photoreceptor), middle (ON-bipolar cell) and inner retinal (amacrine and ganglion cell) components. DMSO induces a dose-dependent decrease in retinal function for concentrations of 0.6% or more which is retinal layer specific. The photoreceptors of the outer retina returned normal responses at all doses (P > 0.05), whereas the mid-retinal bipolar cell response showed dose-dependent losses ranging from 21 +/- 1 to 82 +/- 1% (0.6-8% DMSO; P < 0.05). In a similar dose-dependent fashion, the inner retinal response was also affected by DMSO (0.6-8%: 23 +/- 12 to 98 +/- 3% loss, P < 0.05). A single dose of DMSO < or =0.1% (2.96 x 10(-5) microM) may be safely used to dilute compounds injected into the vitreous of a rat eye. Higher doses produce short-term (at least 24 h) retinal dysfunction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19763650     DOI: 10.1007/s10633-009-9191-8

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  45 in total

1.  Ocular toxicity after intravitreal injection of terconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella; B Colantino
Journal:  Ann Ophthalmol       Date:  1989-09

2.  Noninvasive and simultaneous imaging of layer-specific retinal functional adaptation by manganese-enhanced MRI.

Authors:  Bruce A Berkowitz; Robin Roberts; Dennis J Goebel; Hongmei Luan
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-06       Impact factor: 4.799

3.  Ocular toxicity of experimental intravitreal itraconazole.

Authors:  J A Schulman; G A Peyman; J Dietlein; R Fiscella
Journal:  Int Ophthalmol       Date:  1991-01       Impact factor: 2.031

4.  Induction of proliferating cell nuclear antigen (PCNA)-immunoreactive cells in goldfish retina following intravitreal injection with 6-hydroxydopamine.

Authors:  K Negishi; W K Stell; T Teranishi; A Karkhanis; V Owusu-Yaw; Y Takasaki
Journal:  Cell Mol Neurobiol       Date:  1991-12       Impact factor: 5.046

5.  Comparison of the waveforms of the ON bipolar neuron and the b-wave of the electroretinogram.

Authors:  L Gurevich; M M Slaughter
Journal:  Vision Res       Date:  1993-12       Impact factor: 1.886

6.  A schematic eye for the rat.

Authors:  A Hughes
Journal:  Vision Res       Date:  1979       Impact factor: 1.886

7.  Predicting outcome in central retinal vein occlusion using the flicker electroretinogram.

Authors:  M L Severns; M A Johnson
Journal:  Arch Ophthalmol       Date:  1993-08

8.  Real-time imaging of single nerve cell apoptosis in retinal neurodegeneration.

Authors:  M Francesca Cordeiro; Li Guo; Vy Luong; Glen Harding; Wei Wang; Helen E Jones; Stephen E Moss; Adam M Sillito; Frederick W Fitzke
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-30       Impact factor: 11.205

9.  Effect of dimethyl sulphoxide on oxidative stress, activation of mitogen activated protein kinase and necrosis caused by thioacetamide in the rat liver.

Authors:  Terumi Kishioka; Chinatsu Iida; Kozue Fujii; Ritsuko Nagae; Yuki Onishi; Ikuyo Ichi; Shosuke Kojo
Journal:  Eur J Pharmacol       Date:  2007-03-12       Impact factor: 4.432

10.  Taxol treatment of experimental proliferative vitreoretinopathy.

Authors:  S A Daniels; K G Coonley; M O Yoshizumi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

View more
  12 in total

1.  Post-receptoral contributions to the rat scotopic electroretinogram a-wave.

Authors:  Trung M Dang; Tina I Tsai; Algis J Vingrys; Bang V Bui
Journal:  Doc Ophthalmol       Date:  2011-04-05       Impact factor: 2.379

2.  Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration.

Authors:  Fan Yang; Hongwei Ma; Joshua Belcher; Michael R Butler; T Michael Redmond; Sanford L Boye; William W Hauswirth; Xi-Qin Ding
Journal:  FASEB J       Date:  2016-09-13       Impact factor: 5.191

3.  Slow-release drug delivery through Elvax 40W to the rat retina: implications for the treatment of chronic conditions.

Authors:  Lavinia Fiorani; Rita Maccarone; Nilisha Fernando; Linda Colecchi; Silvia Bisti; Krisztina Valter
Journal:  J Vis Exp       Date:  2014-09-17       Impact factor: 1.355

4.  A p97/Valosin-Containing Protein Inhibitor Drug CB-5083 Has a Potent but Reversible Off-Target Effect on Phosphodiesterase-6.

Authors:  Henri Leinonen; Cheng Cheng; Marja Pitkänen; Christopher L Sander; Jianye Zhang; Sama Saeid; Teemu Turunen; Alyaa Shmara; Lan Weiss; Lac Ta; Timothy Ton; Ari Koskelainen; Jesse D Vargas; Virginia Kimonis; Krzysztof Palczewski
Journal:  J Pharmacol Exp Ther       Date:  2021-04-30       Impact factor: 4.402

5.  Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.

Authors:  Fangfang Qiu; Tuo Meng; Qian Chen; Kelu Zhou; Yan Shao; Greg Matlock; Xiang Ma; Wenjing Wu; Yanhong Du; Xiang Wang; Guotao Deng; Jian-Xing Ma; Qingguo Xu
Journal:  Mol Pharm       Date:  2019-03-26       Impact factor: 5.364

6.  Intraperitoneal administration of apigenin in liver ischemia/reperfusion injury protective effects.

Authors:  Alexandra K Tsaroucha; Anastasia Tsiaousidou; Nikolaos Ouzounidis; Evanthia Tsalkidou; Maria Lambropoulou; Dimitrios Giakoustidis; Ekaterini Chatzaki; Constantinos Simopoulos
Journal:  Saudi J Gastroenterol       Date:  2016-11       Impact factor: 2.485

7.  Emodin protected against retinal ischemia insulted neurons through the downregulation of protein overexpression of β-catenin and vascular endothelium factor.

Authors:  Howard Wen-Haur Chao; Yu-Kuang Chen; Jorn-Hon Liu; Hwai-Tzong Pan; Hsin-May Lin; Hsiao-Ming Chao
Journal:  BMC Complement Med Ther       Date:  2020-11-10

8.  Large-scale phenotypic drug screen identifies neuroprotectants in zebrafish and mouse models of retinitis pigmentosa.

Authors:  Liyun Zhang; Conan Chen; Jie Fu; Brendan Lilley; Cynthia Berlinicke; Baranda Hansen; Ding Ding; Guohua Wang; Tao Wang; Daniel Shou; Ying Ye; Timothy Mulligan; Kevin Emmerich; Meera T Saxena; Kelsi R Hall; Abigail V Sharrock; Carlene Brandon; Hyejin Park; Tae-In Kam; Valina L Dawson; Ted M Dawson; Joong Sup Shim; Justin Hanes; Hongkai Ji; Jun O Liu; Jiang Qian; David F Ackerley; Baerbel Rohrer; Donald J Zack; Jeff S Mumm
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

9.  Sustained and Transient Contributions to the Rat Dark-Adapted Electroretinogram b-Wave.

Authors:  Trung M Dang; Algis J Vingrys; Bang V Bui
Journal:  J Ophthalmol       Date:  2013-03-06       Impact factor: 1.909

10.  The circadian clock modulates anti-cancer properties of curcumin.

Authors:  Ashapurna Sarma; Vishal P Sharma; Arindam B Sarkar; M Chandra Sekar; Karunakar Samuel; Michael E Geusz
Journal:  BMC Cancer       Date:  2016-09-29       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.